Correlation Between Cannara Biotech and Blueberries Medical

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Blueberries Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Blueberries Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Blueberries Medical Corp, you can compare the effects of market volatilities on Cannara Biotech and Blueberries Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Blueberries Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Blueberries Medical.

Diversification Opportunities for Cannara Biotech and Blueberries Medical

-0.49

Correlation Coefficient

Cannara Biotech  Blueberries Medical

Very good diversification

The 3 months correlation between Cannara and Blueberries is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Blueberries Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueberries Medical Corp and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Blueberries Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueberries Medical Corp has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Blueberries Medical go up and down completely randomly.

Pair Corralation between Cannara Biotech and Blueberries Medical

Assuming the 90 days horizon Cannara Biotech is expected to generate 13.85 times less return on investment than Blueberries Medical. But when comparing it to its historical volatility, Cannara Biotech is 2.82 times less risky than Blueberries Medical. It trades about 0.01 of its potential returns per unit of risk. Blueberries Medical Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.73  in Blueberries Medical Corp on September 29, 2024 and sell it today you would lose (0.65) from holding Blueberries Medical Corp or give up 37.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.6%
Values	Daily Returns

Cannara Biotech  vs.  Blueberries Medical Corp

Cannara Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Blueberries Medical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Blueberries Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Blueberries Medical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Cannara Biotech and Blueberries Medical

The main advantage of trading using opposite Cannara Biotech and Blueberries Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Blueberries Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueberries Medical will offset losses from the drop in Blueberries Medical's long position.

The idea behind Cannara Biotech and Blueberries Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.